Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Quality Systems No Longer Theoretical as Industry Begins Implementing Concepts

This article was originally published in The Gold Sheet

Executive Summary

Alignment of reality with ICH quality systems theory is under way. Industry is developing, promoting and implementing global solutions through ISPE's new PQLI process, with the involvement of regional regulators. Conformia's new, more complex mock P2 could kindle more QbD. Genentech's approach to QbD described in detail. Quality systems seen as an option you can't refuse. Lessons from the device sector. Why Lilly switched to quality systems and how it benefited. How Abbott prepares for the future with management reviews. What Amgen did to correct its CAPA process - and save millions of dollars along the way

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts